Meshalkin Research Institute Of Pathology Of Circulation
Clinical trials sponsored by Meshalkin Research Institute Of Pathology Of Circulation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pacing technique aims to prevent heart failure in High-Risk HCM patients Results expected May 2027 (estimated)
-
Calcium timing during bypass may cut need for heart drugs
Disease control CompletedThis trial tests whether giving calcium chloride as patients come off cardiopulmonary bypass reduces the need for drugs that support the heart and blood pressure. About 800 adults having valve or combined valve-and-bypass surgery will receive either calcium or a placebo. The goal…
Phase 4 • Sponsor: Meshalkin Research Institute of Pathology of Circulation • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Nerve freezing cuts opioid use after heart surgery?
Symptom relief CompletedThis study tested whether freezing certain nerves in the chest (cryoablation) can reduce pain and the need for strong painkillers after minimally invasive mitral valve surgery. Thirty adults took part, and researchers measured pain levels and opioid use. The goal was to gather ea…
Sponsor: Meshalkin Research Institute of Pathology of Circulation • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC